Abstract:Background: Aging is characterized by the gradual loss of physiological integrity, resulting in impaired function and easier death. This deterioration is a major risk factor for major human pathological diseases, including cancer, diabetes, cardiovascular disease and neurodegenerative diseases. It is very important to find biomarkers that can prevent aging. Methods: Q-Exactive-MS was used for proteomic detection of young and senescence fibroblast. The key senescence-related molecules (SRMs) were identified by integrating transcriptome and proteomics from aging tissue/cells, and the correlation between these differentially expressed genes and well-known aging-related pathways. Next, we validated the expression of these molecules using qPCR, and explored the correlation between them and immune infiltrating cells. Finally, the enriched pathways of the genes significantly related to the four differential genes were identified using the single cell transcriptome. Results: we first combined proteomics and transcriptome to identified four SRMs . Data sets including GSE63577, GSE64553, GSE18876, GSE85358, and qPCR confirmed that ETF1, PLBD2, ASAH1, and MOXD1 were identified as SRMs. Then the correlation between SRMs and aging-related pathways was excavated and verified. Next, we verified the expression of SRMs at the tissue level and qPCR, and explored the correlation between them and immune infiltrating cells. Finally, at the single-cell transcriptome level, we verified their expression and explored the possible pathway by which they lead to aging. Briefly, ETF1 may affect the changes of inflammatory factors such as IL-17, IL-6, and NFKB1 by indirectly regulating the enrichment and differentiation of immune cells. MOXD1 may regulate senescence by affecting the WNT pathway and changing the cell cycle. ASAH1 may affect development and regulate the phenotype of aging by affecting cell cycle-related genes. Conclusion: In general, based on the analysis of proteomics and transcriptome, we identified four SRMs that may affect aging and speculated their possible mechanisms, which provides a new target for preventing aging, especially skin aging.

Investigation of human aging at the single-cell level

Unveiling Aging Dynamics in the Hematopoietic System Insights from Single-Cell Technologies

Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets.

Exploring the heterogeneous targets of metabolic aging at single-cell resolution

Deciphering the aging process through single‐cell cytometric technologies

A Single-Cell Transcriptomic Atlas of Human Skin Aging

Unraveling aging from transcriptomics

Models for Evaluation of Biological Age Based on Multi-omics

Forward single-cell sequencing into clinical application: Understanding of ageing and rejuvenation from clinical observation to single-cell solution

Integrated multi-omics approach revealed cellular senescence landscape

A Panoramic View of Cell Population Dynamics in Mammalian Aging

Systems Approaches to Understanding Aging

Decoding Aging in the Heart Via Single Cell Dual Omics of Non-Cardiomyocytes

Nonlinear dynamics of multi-omics profiles during human aging

Systems Biology in Aging Research

Haematopoietic ageing through the lens of single-cell technologies

Identification of Four Biomarkers of Human Skin Aging by Comprehensive Single Cell Transcriptome, Transcriptome, and Proteomics

Integrated analyses of the single-cell ATAC-seq and RNA-seq reveal the epigenetic landscape of human ovarian aging

Systems-level Analysis of Human Aging Genes Shed New Light on Mechanisms of Aging.

Cardiac Aging in the Multi-Omics Era: High-Throughput Sequencing Insights

Biomarkers of Cellular Senescence and Aging: Current State-of-the-Art, Challenges and Future Perspectives